Wednesday, January 28, 2026 | 06:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Caplin Point Laboratories Ltd / Announcements / BSE

Caplin Point Laboratories Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

03:28 PM, 27th Jan 2026

Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.

More Caplin Point Laboratories Ltd Announcements

    View more